4//SEC Filing
Laube Lynne Marie 4
Accession 0001666071-22-000062
CIK 0001666071other
Filed
May 8, 8:00 PM ET
Accepted
May 9, 4:10 PM ET
Size
7.1 KB
Accession
0001666071-22-000062
Insider Transaction Report
Form 4
Cardlytics, Inc.CDLX
Laube Lynne Marie
DirectorChief Operating Officer
Transactions
- Sale
Common Stock
2022-05-05$33.60/sh−17,973$603,893→ 358,530 total
Holdings
- 14,565(indirect: See Footnote)
Common Stock
- 14,565(indirect: See Footnote)
Common Stock
Footnotes (4)
- [F1]Shares sold to satisfy withholding tax obligations upon the delivery of shares of common stock for restricted stock units that vested on March 24, 2022, April 1, 2022 and April 5, 2022 and performance stock units that vested on April 6, 2022.
- [F2]The price reported is a weighted average sales price. These shares were sold in multiple transactions at prices ranging from $33.30 to $33.97, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (2) to this Form 4.
- [F3]The reportable securities are held by the 2013 Lynne Marie Laube GRAT fbo Keegan George Allbright.
- [F4]The reportable securities are held by the 2013 Lynne Marie Laube GRAT fbo Hayley Marie Allbright.
Documents
Issuer
Cardlytics, Inc.
CIK 0001666071
Entity typeother
Related Parties
1- filerCIK 0001730687
Filing Metadata
- Form type
- 4
- Filed
- May 8, 8:00 PM ET
- Accepted
- May 9, 4:10 PM ET
- Size
- 7.1 KB